Alpelisib
SHARE
Molecule Summary
| Uses | Advanced or metastatic breast cancer |
| Therapy | Anti-Neoplastic |
| Side Effects | Nausea, Vomiting, Decreased appetite, Diarrhoea or colitis, Abdominal pain, Rash |
Medicines
available
19k pincodes
Molecule Description
Alpelisib is an anticancer medicine. It is a PI3K inhibitor used to treat breast cancer in patients who are HR-positive, HER2-negative, diagnosed with PIK3CA-mutated, advanced or metastatic breast cancer. It is given in conjunction with another medication known as fulvestrant and is appropriate for both postmenopausal women and men. Before the treatment, your doctor may give you medication to prevent nausea and vomiting. During treatment and for one week after the last dose, women should use an effective form of birth control. Male patients with female partners should use effective birth control during treatment as well as for one week after the last dose. If you have kidney disease, lung disease or breathing problems, or diabetes, tell your doctor. Do not breastfeed while taking this medication or for 1 week after the last dose.
Uses
- Advanced or metastatic breast cancer
Contraindications
When should one not use Alpelisib
- Allergy to any of the components
- Pregnancy
- Breastfeeding
Side effects
Common side effects of this drug are:
- Nausea
- Vomiting
- Decreased appetite
- Diarrhoea or colitis
- Abdominal pain
- Rash
- Tiredness or weakness
- Weight loss
- Mouth sores
- Hair loss
- Changes in blood test results
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
Talk to your doctor if
- You are allergic to any of the ingredients
- You have a history of diabetes
- You had or have a skin rash, blisters, redness
- You are pregnant or plan to become pregnant, as it may cause harm to an unborn baby.
- You are taking any other medications, including prescription, over-the-counter, or herbal supplements, as they may affect each other, causing side effects
- Use effective birth control during the treatment and till 1 week after the last dose.
- Do not breastfeed during the treatment and till 1 week after the last dose
Mode of Action
How Does It Work?
Alpelisib selectively inhibits the activity of PI3K enzyme involved in various biological processes, including proliferation, survival, differentiation, and metabolism. Alpelisib targets this enzyme that appears to be mutated, leading to hyperactivation and cancer cell growth. Thus, Alpelisib results in the inhibition of the growth and survival of cancer cells.
Dosage
Overdose
In the event of an overdose, report to your doctor immediately.
Missed a Dose
Report to your doctor immediately. Do not take extra doses to compensate for missed doses.
Frequently Asked Questions (FAQs)
Articles
View AllDid you find this helpful?
Explore More at Pharmeasy
Why trust PharmEasy?
# ONE OF INDIA'S MOST TRUSTED HEALTHCARE PLATFORM
CODAvailable
100%Genuine Medicine
30 DAYReturn Policy









